PASG

Passage BIO, Inc.CIK 1787297 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for PASG PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for PASG

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Nichols Weston	10% Owner	4	$430.0K	$0	2026-06-25
Sondhi Dolan	Director	4	$0	$0	2026-05-19
Porter Derrell	Director	6	$0	$0	2026-05-19
Kapadia Sandip	Director	9	$90.0K	$6.0K	2026-05-19
Countouriotis Athena	Director	9	$310.0K	$0	2026-05-19
Kassberg Thomas Richard	Director	3	$0	$0	2026-05-19
GOWEN MAXINE	Director	8	$0	$0	2026-05-19
Borthwick Kathleen	SVP, Interim CFO	17	$0	$50.8K	2026-03-16
Chou William	President and CEO	9	$0	$75.2K	2026-03-16
Lynx1 Capital Management LP	10% Owner	7	$1.26M	$0	2025-07-24
ORBIMED ADVISORS LLC	10% Owner	16	$1.26M	$498.1K	2025-06-26
Islam Saqib	Director	7	$90.0K	$0	2025-05-28
OrbiMed Capital GP VII LLC	10% Owner	28	$11.48M	$515.3K	2025-04-17
Cale Edgar B.	Interim CEO, GC & Corp. Sec.	14	$36.0K	$14.4K	2025-03-15
Forman Mark S	Chief Medical Officer	14	$0	$16.0K	2024-03-15
King Simona	Chief Financial Officer	12	$0	$12.2K	2023-07-28
Fotopoulos Alexandros	Chief Technical Officer	14	$99.0K	$8.7K	2023-06-16
Woiwode Thomas	Director, 10% Owner	11	$4.05M	$0	2023-05-25
Kamarck Michael E.	Director	2	$0	$0	2023-05-25
Toernsen Monika Maria	Chief Commercial Officer	7	$0	$2.5K	2022-09-19
Goldsmith Bruce A	CEO and President	6	$77.5K	$0	2022-05-27
Salinas Eliseo Oreste	Chief Res. & Develop Officer	4	$0	$0	2022-02-10
Quigley Jill M.	Chief Operating Officer	9	$45.0K	$529.6K	2021-12-08
Ratcliffe Liam	Director	7	$10.00M	$0	2021-05-27
Yamada Tadataka	Director	3	$117.0K	$0	2021-05-27
Morris Richard Steven	Chief Financial Officer	4	$37.2K	$0	2021-05-21
Romano Gary	Chief Medical Officer	6	$0	$211.0K	2021-03-15
FHMLS IX, L.P.	10% Owner	7	$9.90M	$0	2020-03-03
Versant Ventures VI GP, L.P.	10% Owner	7	$4.05M	$0	2020-03-03
Heron Patrick J	Director, 10% Owner	8	$9.90M	$0	2020-03-03
SQUINTO STEPHEN P	Head of Research and Dev	2	$0	$0	2020-02-27

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Nichols Weston	10% Owner	P Buy	2026-06-25	2026-06-29	50,055	$4.12	$206.2K	673,759	SEC↗
Countouriotis Athena	Director	A Award deriv	2026-05-19	2026-05-21	10,539	—	$0	10,539	SEC↗
GOWEN MAXINE	Director	A Award deriv	2026-05-19	2026-05-21	10,539	—	$0	10,539	SEC↗
Kapadia Sandip	Director	A Award deriv	2026-05-19	2026-05-21	10,539	—	$0	10,539	SEC↗
Kassberg Thomas Richard	Director	A Award deriv	2026-05-19	2026-05-21	10,539	—	$0	10,539	SEC↗
Porter Derrell	Director	A Award deriv	2026-05-19	2026-05-21	10,539	—	$0	10,539	SEC↗
Sondhi Dolan	Director	A Award deriv	2026-05-19	2026-05-21	10,539	—	$0	10,539	SEC↗
Chou William	PRESIDENT AND CEO	A Award deriv	2026-03-16	2026-03-18	58,000	—	$0	58,000	SEC↗
Borthwick Kathleen	CFO	A Award deriv	2026-03-16	2026-03-18	15,610	—	$0	15,610	SEC↗
Borthwick Kathleen	CFO	M Exercise deriv	2026-01-08	2026-01-12	5,000	—	$0	5,000	SEC↗
Chou William	PRESIDENT AND CEO	M Exercise deriv	2026-01-08	2026-01-12	10,000	—	$0	10,000	SEC↗
Borthwick Kathleen	CFO	S Sale	2026-01-08	2026-01-12	2,062	$18.44	$38.0K	5,402	SEC↗
Borthwick Kathleen	CFO	M Exercise	2026-01-08	2026-01-12	5,000	—	$0	7,464	SEC↗
Chou William	PRESIDENT AND CEO	S Sale	2026-01-08	2026-01-12	4,076	$18.44	$75.2K	6,524	SEC↗
Chou William	PRESIDENT AND CEO	M Exercise	2026-01-08	2026-01-12	10,000	—	$0	10,600	SEC↗
Nichols Weston	10% Owner	P Buy	2025-09-15	2025-09-15	11,900	$6.99	$83.2K	623,704	SEC↗
Nichols Weston	10% Owner	P Buy	2025-09-12	2025-09-15	19,783	$6.99	$138.3K	611,804	SEC↗
Nichols Weston	10% Owner	P Buy	2025-09-11	2025-09-15	325	$6.96	$2.3K	592,021	SEC↗
Lynx1 Capital Management LP	10% Owner	P Buy	2025-07-24	2025-07-24	66,423	$5.71	$379.3K	591,696	SEC↗
Lynx1 Capital Management LP	10% Owner	P Buy	2025-07-23	2025-07-24	49,302	$5.74	$283.0K	525,273	SEC↗
Lynx1 Capital Management LP	10% Owner	P Buy	2025-07-22	2025-07-24	13,123	$5.44	$71.4K	475,971	SEC↗
ORBIMED ADVISORS LLC	10% Owner	S Sale	2025-06-26	2025-06-26	213,257	$0.33	$70.4K	6,066,343	SEC↗
ORBIMED ADVISORS LLC	10% Owner	S Sale	2025-06-25	2025-06-26	138,800	$0.33	$45.8K	6,279,600	SEC↗
ORBIMED ADVISORS LLC	10% Owner	S Sale	2025-06-24	2025-06-26	231,600	$0.35	$81.1K	6,418,400	SEC↗
Kassberg Thomas Richard	Director	A Award deriv	2025-05-28	2025-05-30	143,789	—	$0	143,789	SEC↗
Sondhi Dolan	Director	A Award deriv	2025-05-28	2025-05-30	201,857	—	$0	201,857	SEC↗
Islam Saqib	Director	A Award deriv	2025-05-28	2025-05-30	201,857	—	$0	201,857	SEC↗
Porter Derrell	Director	A Award deriv	2025-05-28	2025-05-30	201,857	—	$0	201,857	SEC↗
Countouriotis Athena	Director	A Award deriv	2025-05-28	2025-05-30	201,857	—	$0	201,857	SEC↗
GOWEN MAXINE	Director	A Award deriv	2025-05-28	2025-05-30	201,857	—	$0	201,857	SEC↗
Kapadia Sandip	Director	A Award deriv	2025-05-28	2025-05-30	201,857	—	$0	201,857	SEC↗
ORBIMED ADVISORS LLC	10% Owner	S Sale	2025-04-24	2025-04-24	68,195	$0.32	$21.8K	6,650,000	SEC↗
ORBIMED ADVISORS LLC	10% Owner	S Sale	2025-04-23	2025-04-24	89,328	$0.34	$30.4K	6,718,195	SEC↗
ORBIMED ADVISORS LLC	10% Owner	S Sale	2025-04-22	2025-04-24	78,049	$0.34	$26.5K	6,807,523	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	S Sale	2025-04-17	2025-04-17	77,090	$0.33	$25.4K	6,885,572	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	S Sale	2025-04-16	2025-04-17	61,638	$0.33	$20.3K	6,962,662	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	S Sale	2025-04-15	2025-04-17	10,326	$0.38	$3.9K	7,024,300	SEC↗
Cale Edgar B.	GC & CORPORATE SECRETARY	A Award deriv	2025-03-15	2025-03-18	278,386	—	$0	278,386	SEC↗
Chou William	PRESIDENT AND CEO	A Award deriv	2025-03-15	2025-03-18	779,533	—	$0	779,533	SEC↗
Borthwick Kathleen	CFO	A Award deriv	2025-03-15	2025-03-18	278,386	—	$0	278,386	SEC↗
Borthwick Kathleen	CFO	S Sale	2025-02-11	2025-02-12	3,183	$0.53	$1.7K	41,283	SEC↗
Borthwick Kathleen	CFO	M Exercise deriv	2025-02-10	2025-02-12	8,000	—	$0	0	SEC↗
Borthwick Kathleen	CFO	M Exercise	2025-02-10	2025-02-12	8,000	—	$0	44,466	SEC↗
Chou William	PRESIDENT AND CEO	A Award deriv	2025-01-15	2025-12-29	20,000	—	$0	20,000	SEC↗
Borthwick Kathleen	CFO	A Award deriv	2025-01-15	2025-12-29	10,000	—	$0	10,000	SEC↗
ORBIMED ADVISORS LLC	10% Owner	S Sale	2025-01-14	2025-01-14	79,024	$0.60	$47.4K	7,034,626	SEC↗
ORBIMED ADVISORS LLC	10% Owner	S Sale	2025-01-13	2025-01-14	17,986	$0.64	$11.5K	7,113,650	SEC↗
ORBIMED ADVISORS LLC	10% Owner	S Sale	2025-01-10	2025-01-14	126,209	$0.66	$83.3K	7,131,636	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	S Sale	2025-01-08	2025-01-08	75,007	$0.68	$51.0K	7,257,845	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	S Sale	2025-01-07	2025-01-08	52,536	$0.71	$37.3K	7,332,852	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	S Sale	2025-01-06	2025-01-08	19,481	$0.77	$15.0K	7,385,388	SEC↗
Lynx1 Capital Management LP	10% Owner	P Buy	2024-12-27	2024-12-31	373,645	$0.65	$242.9K	9,256,953	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	S Sale	2024-12-20	2024-12-26	230,321	$0.60	$138.2K	7,404,869	SEC↗
ORBIMED ADVISORS LLC	10% Owner	S Sale	2024-12-11	2024-12-11	80	$0.80	$64	7,635,190	SEC↗
ORBIMED ADVISORS LLC	10% Owner	S Sale	2024-12-10	2024-12-11	8,015	$0.80	$6.4K	7,635,270	SEC↗
ORBIMED ADVISORS LLC	10% Owner	S Sale	2024-12-09	2024-12-11	54,181	$0.84	$45.5K	7,643,285	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	S Sale	2024-12-06	2024-12-06	20,903	$0.82	$17.1K	7,697,466	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	S Sale	2024-12-04	2024-12-06	76,200	$0.79	$60.2K	7,718,369	SEC↗
Lynx1 Capital Management LP	10% Owner	P Buy	2024-11-27	2024-11-27	29,300	$0.67	$19.6K	8,883,308	SEC↗
Lynx1 Capital Management LP	10% Owner	P Buy	2024-11-26	2024-11-27	167,055	$0.71	$118.6K	8,854,008	SEC↗
Lynx1 Capital Management LP	10% Owner	P Buy	2024-11-25	2024-11-27	259,998	$0.56	$145.6K	8,686,953	SEC↗
Kassberg Thomas Richard	Director	A Award deriv	2024-09-30	2024-10-02	174,139	—	$0	174,139	SEC↗
Cale Edgar B.	GC & CORPORATE SECRETARY	A Award deriv	2024-09-30	2024-10-02	50,000	—	$0	50,000	SEC↗
ORBIMED ADVISORS LLC	10% Owner	S Sale	2024-09-19	2024-09-23	39,300	$0.71	$27.9K	7,794,569	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	S Sale	2024-09-18	2024-09-18	25,631	$0.73	$18.7K	7,833,869	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	S Sale	2024-09-17	2024-09-18	111,400	$0.73	$81.3K	7,859,500	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	S Sale	2024-09-16	2024-09-18	63,100	$0.74	$46.7K	7,970,900	SEC↗
Porter Derrell	Director	A Award deriv	2024-05-21	2024-05-23	47,693	—	$0	47,693	SEC↗
Sondhi Dolan	Director	A Award deriv	2024-05-21	2024-05-23	39,092	—	$0	39,092	SEC↗
Islam Saqib	Director	A Award deriv	2024-05-21	2024-05-23	47,693	—	$0	47,693	SEC↗
Kapadia Sandip	Director	A Award deriv	2024-05-21	2024-05-23	47,693	—	$0	47,693	SEC↗
GOWEN MAXINE	Director	A Award deriv	2024-05-21	2024-05-23	47,693	—	$0	47,693	SEC↗
Countouriotis Athena	Director	A Award deriv	2024-05-21	2024-05-23	47,693	—	$0	47,693	SEC↗
Cale Edgar B.	GC & CORPORATE SECRETARY	A Award deriv	2024-03-15	2024-03-19	203,000	—	$0	203,000	SEC↗
Chou William	PRESIDENT AND CEO	A Award deriv	2024-03-15	2024-03-19	575,000	—	$0	575,000	SEC↗
Forman Mark S	CHIEF MEDICAL OFFICER	A Award deriv	2024-03-15	2024-03-19	203,000	—	$0	203,000	SEC↗
Borthwick Kathleen	CFO	A Award deriv	2024-03-15	2024-03-19	227,000	—	$0	227,000	SEC↗
Forman Mark S	CHIEF MEDICAL OFFICER	S Sale	2024-02-13	2024-02-13	1,638	$0.97	$1.6K	48,631	SEC↗
Borthwick Kathleen	SVP, INTERIM CFO	S Sale	2024-02-13	2024-02-13	1,470	$0.97	$1.4K	28,466	SEC↗
Forman Mark S	CHIEF MEDICAL OFFICER	M Exercise deriv	2024-02-10	2024-02-13	5,000	—	$0	10,000	SEC↗
Borthwick Kathleen	SVP, INTERIM CFO	M Exercise deriv	2024-02-10	2024-02-13	4,000	—	$0	8,000	SEC↗
Forman Mark S	CHIEF MEDICAL OFFICER	M Exercise	2024-02-10	2024-02-13	5,000	—	$0	50,269	SEC↗
Borthwick Kathleen	SVP, INTERIM CFO	M Exercise	2024-02-10	2024-02-13	4,000	—	$0	29,936	SEC↗
Cale Edgar B.	GC & Corporate Secretary	S Sale	2024-01-02	2024-01-03	15,813	$0.91	$14.4K	45,995	SEC↗
Borthwick Kathleen	SVP, Interim CFO	S Sale	2024-01-02	2024-01-03	10,672	$0.91	$9.7K	25,936	SEC↗
Forman Mark S	Chief Medical Officer	S Sale	2024-01-02	2024-01-03	15,813	$0.91	$14.4K	45,269	SEC↗
Cale Edgar B.	GC & Corporate Secretary	M Exercise deriv	2023-12-31	2024-01-03	50,000	—	$0	0	SEC↗
Borthwick Kathleen	SVP, Interim CFO	M Exercise deriv	2023-12-31	2024-01-03	30,000	—	$0	0	SEC↗
Forman Mark S	Chief Medical Officer	M Exercise deriv	2023-12-31	2024-01-03	50,000	—	$0	0	SEC↗
Cale Edgar B.	GC & Corporate Secretary	M Exercise	2023-12-31	2024-01-03	50,000	—	$0	61,808	SEC↗
Borthwick Kathleen	SVP, Interim CFO	M Exercise	2023-12-31	2024-01-03	30,000	—	$0	36,608	SEC↗
Forman Mark S	Chief Medical Officer	M Exercise	2023-12-31	2024-01-03	50,000	—	$0	61,082	SEC↗
Borthwick Kathleen	SVP, Interim CFO	A Award deriv	2023-07-28	2023-07-28	20,000	—	$0	20,000	SEC↗
King Simona	Chief Financial Officer	M Exercise deriv	2023-07-28	2023-08-01	31,250	—	$0	0	SEC↗
King Simona	Chief Financial Officer	S Sale	2023-07-28	2023-08-01	11,453	$0.88	$10.1K	23,994	SEC↗
King Simona	Chief Financial Officer	M Exercise	2023-07-28	2023-08-01	31,250	—	$0	35,447	SEC↗
Sondhi Dolan	Director	A Award deriv	2023-07-27	2023-07-31	48,000	—	$0	48,000	SEC↗
ORBIMED ADVISORS LLC	10% Owner	P Buy	2023-06-28	2023-06-29	575,195	$0.84	$483.2K	8,034,000	SEC↗
ORBIMED ADVISORS LLC	10% Owner	P Buy	2023-06-27	2023-06-29	617,382	$0.84	$518.6K	7,458,805	SEC↗
Fotopoulos Alexandros	Chief Technical Officer	S Sale	2023-06-16	2023-06-20	4,052	$0.93	$3.8K	28,693	SEC↗
Fotopoulos Alexandros	Chief Technical Officer	M Exercise deriv	2023-06-15	2023-06-20	12,500	—	$0	25,000	SEC↗
Fotopoulos Alexandros	Chief Technical Officer	M Exercise	2023-06-15	2023-06-20	12,500	—	$0	32,745	SEC↗
Countouriotis Athena	Director	A Award deriv	2023-05-25	2023-05-26	24,000	—	$0	24,000	SEC↗
GOWEN MAXINE	Director	A Award deriv	2023-05-25	2023-05-26	24,000	—	$0	24,000	SEC↗
Islam Saqib	Director	A Award deriv	2023-05-25	2023-05-26	24,000	—	$0	24,000	SEC↗
Kamarck Michael E.	Director	A Award deriv	2023-05-25	2023-05-26	21,567	—	$0	21,567	SEC↗
Kapadia Sandip	Director	A Award deriv	2023-05-25	2023-05-26	24,000	—	$0	24,000	SEC↗
Porter Derrell	Director	A Award deriv	2023-05-25	2023-05-26	24,000	—	$0	24,000	SEC↗
Woiwode Thomas	Director, 10% Owner	A Award deriv	2023-05-25	2023-05-26	24,000	—	$0	24,000	SEC↗
King Simona	Chief Financial Officer	M Exercise deriv	2023-04-18	2023-04-20	6,250	—	$0	18,750	SEC↗
King Simona	Chief Financial Officer	S Sale	2023-04-18	2023-04-20	2,053	$1.05	$2.2K	2,053	SEC↗
King Simona	Chief Financial Officer	M Exercise	2023-04-18	2023-04-20	6,250	—	$0	6,250	SEC↗
Fotopoulos Alexandros	Chief Technical Officer	A Award deriv	2023-03-15	2023-04-05	175,000	—	$0	175,000	SEC↗
Cale Edgar B.	GC & Corporate Secretary	A Award deriv	2023-03-15	2023-04-05	175,000	—	$0	175,000	SEC↗
Forman Mark S	Chief Medical Officer	A Award deriv	2023-03-15	2023-04-05	175,000	—	$0	175,000	SEC↗
King Simona	Chief Financial Officer	A Award deriv	2023-03-15	2023-04-05	140,000	—	$0	140,000	SEC↗
Chou William	President and CEO	A Award deriv	2023-03-15	2023-04-05	608,615	—	$0	608,615	SEC↗
Kapadia Sandip	Director	S Sale	2022-12-01	2022-12-02	5,000	$1.19	$6.0K	0	SEC↗
Fotopoulos Alexandros	Chief Technical Officer	M Exercise deriv	2022-11-22	2022-11-25	12,500	—	$0	37,500	SEC↗
Fotopoulos Alexandros	Chief Technical Officer	S Sale	2022-11-22	2022-11-25	3,720	$1.33	$4.9K	20,245	SEC↗
Fotopoulos Alexandros	Chief Technical Officer	M Exercise	2022-11-22	2022-11-25	12,500	—	$0	23,965	SEC↗
Fotopoulos Alexandros	Chief Technical Officer	A Award deriv	2022-11-10	2022-11-14	50,000	—	$0	50,000	SEC↗
Cale Edgar B.	GC & Corporate Secretary	A Award deriv	2022-11-10	2022-11-14	50,000	—	$0	50,000	SEC↗
Forman Mark S	Chief Medical Officer	A Award deriv	2022-11-10	2022-11-14	50,000	—	$0	50,000	SEC↗
King Simona	Chief Financial Officer	A Award deriv	2022-11-10	2022-11-14	50,000	—	$0	50,000	SEC↗
Chou William	Chief Executive Officer	A Award deriv	2022-10-10	2022-10-12	885,000	—	$0	885,000	SEC↗
Toernsen Monika Maria	Chief Commercial Officer	S Sale	2022-09-19	2022-11-18	1,681	$1.51	$2.5K	3,319	SEC↗
Toernsen Monika Maria	Chief Commercial Officer	M Exercise deriv	2022-09-15	2022-11-18	5,000	—	$0	15,000	SEC↗
Toernsen Monika Maria	Chief Commercial Officer	M Exercise	2022-09-15	2022-11-18	5,000	—	$0	5,000	SEC↗
Kamarck Michael E.	Director	A Award deriv	2022-07-05	2022-07-06	48,000	—	$0	48,000	SEC↗
Fotopoulos Alexandros	Chief Technical Officer	A Award deriv	2022-06-13	2022-06-15	200,000	—	$0	200,000	SEC↗
Cale Edgar B.	Interim CEO, GC & Corp. Sec.	A Award deriv	2022-06-13	2022-06-15	106,000	—	$0	106,000	SEC↗
Forman Mark S	Chief Medical Officer	A Award deriv	2022-06-13	2022-06-15	136,000	—	$0	136,000	SEC↗
King Simona	Chief Financial Officer	A Award deriv	2022-06-13	2022-06-15	159,000	—	$0	159,000	SEC↗
Toernsen Monika Maria	Chief Commercial Officer	A Award deriv	2022-06-13	2022-06-15	101,000	—	$0	101,000	SEC↗
Cale Edgar B.	Interim CEO, GC & Corp. Sec.	A Award deriv	2022-05-31	2022-06-01	100,000	—	$0	100,000	SEC↗
GOWEN MAXINE	Director	A Award deriv	2022-05-31	2022-06-01	40,000	—	$0	40,000	SEC↗
Goldsmith Bruce A	CEO and President	A Award deriv	2022-05-27	2022-06-01	100,000	—	$0	100,000	SEC↗
Countouriotis Athena	Director	A Award deriv	2022-05-26	2022-05-31	24,000	—	$0	24,000	SEC↗
GOWEN MAXINE	Director	A Award deriv	2022-05-26	2022-05-31	24,000	—	$0	24,000	SEC↗
Islam Saqib	Director	A Award deriv	2022-05-26	2022-05-31	24,000	—	$0	24,000	SEC↗
Kapadia Sandip	Director	A Award deriv	2022-05-26	2022-05-31	24,000	—	$0	24,000	SEC↗
Porter Derrell	Director	A Award deriv	2022-05-26	2022-05-31	24,000	—	$0	24,000	SEC↗
Woiwode Thomas	Director, 10% Owner	A Award deriv	2022-05-26	2022-05-31	24,000	—	$0	24,000	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	P Buy	2022-05-04	2022-05-05	303,500	$1.94	$588.8K	6,841,423	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	P Buy	2022-05-03	2022-05-05	221,500	$1.93	$427.5K	6,537,923	SEC↗
Forman Mark S	Chief Medical Officer	A Award deriv	2022-04-18	2022-04-20	136,000	—	$0	136,000	SEC↗
King Simona	Chief Financial Officer	A Award deriv	2022-04-18	2022-04-20	25,000	—	$0	25,000	SEC↗
Goldsmith Bruce A	CEO and President	P Buy	2022-03-21	2022-03-23	10,000	$3.15	$31.5K	15,983	SEC↗
Forman Mark S	CHIEF MEDICAL OFFICER	A Award deriv	2022-02-10	2024-02-13	25,000	—	$0	25,000	SEC↗
Forman Mark S	CHIEF MEDICAL OFFICER	A Award deriv	2022-02-10	2024-02-13	15,000	—	$0	15,000	SEC↗
Cale Edgar B.	GC and Corporate Secretary	A Award deriv	2022-02-10	2022-02-14	106,000	—	$0	106,000	SEC↗
Goldsmith Bruce A	CEO and President	A Award deriv	2022-02-10	2022-02-14	400,000	—	$0	400,000	SEC↗
King Simona	Chief Financial Officer	A Award deriv	2022-02-10	2022-02-14	159,000	—	$0	159,000	SEC↗
Fotopoulos Alexandros	Chief Technical Officer	A Award deriv	2022-02-10	2022-02-14	163,900	—	$0	163,900	SEC↗
Salinas Eliseo Oreste	Chief Res. & Develop Officer	A Award deriv	2022-02-10	2022-02-14	157,500	—	$0	157,500	SEC↗
Toernsen Monika Maria	Chief Commercial Officer	A Award deriv	2022-02-10	2022-02-14	101,000	—	$0	101,000	SEC↗
ORBIMED ADVISORS LLC	10% Owner	P Buy	2022-01-20	2022-05-05	50,800	$5.00	$254.0K	6,316,423	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	P Buy	2022-01-20	2022-01-24	369,100	$5.42	$2.00M	6,634,723	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	P Buy	2022-01-19	2022-01-20	43,300	$5.11	$221.3K	6,265,623	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	P Buy	2022-01-18	2022-01-20	114,700	$5.46	$626.3K	6,222,323	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	P Buy	2022-01-14	2022-01-20	10,300	$5.60	$57.7K	6,107,623	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	P Buy	2022-01-13	2022-01-13	41,800	$5.52	$230.7K	6,097,323	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	P Buy	2022-01-12	2022-01-13	100,000	$5.65	$565.0K	6,055,523	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	P Buy	2022-01-11	2022-01-13	8,200	$5.53	$45.3K	5,955,523	SEC↗
Quigley Jill M.	Chief Operating Officer	M Exercise deriv	2021-12-08	2021-12-10	60,782	—	$0	27,626	SEC↗
Quigley Jill M.	Chief Operating Officer	M Exercise deriv	2021-12-08	2021-12-10	11,193	—	$0	3,729	SEC↗
Quigley Jill M.	Chief Operating Officer	M Exercise	2021-12-08	2021-12-10	71,975	$0.23	$16.6K	368,754	SEC↗
King Simona	Chief Financial Officer	A Award deriv	2021-08-23	2021-08-25	360,000	—	$0	360,000	SEC↗
Forman Mark S	CHIEF MEDICAL OFFICER	A Award deriv	2021-08-16	2024-02-13	130,000	—	$0	130,000	SEC↗
Toernsen Monika Maria	Chief Commercial Officer	A Award deriv	2021-07-19	2021-07-21	200,000	—	$0	200,000	SEC↗
Toernsen Monika Maria	Chief Commercial Officer	A Award deriv	2021-07-19	2021-07-21	20,000	—	$0	20,000	SEC↗
Countouriotis Athena	Director	A Award deriv	2021-05-27	2021-05-28	16,918	—	$0	16,918	SEC↗
Porter Derrell	Director	A Award deriv	2021-05-27	2021-05-28	33,836	—	$0	33,836	SEC↗
Ratcliffe Liam	Director	A Award deriv	2021-05-27	2021-05-28	16,918	—	$0	16,918	SEC↗
Kapadia Sandip	Director	A Award deriv	2021-05-27	2021-05-28	16,918	—	$0	16,918	SEC↗
Islam Saqib	Director	A Award deriv	2021-05-27	2021-05-28	16,918	—	$0	16,918	SEC↗
Yamada Tadataka	Director	A Award deriv	2021-05-27	2021-05-28	16,918	—	$0	16,918	SEC↗
Woiwode Thomas	Director, 10% Owner	A Award deriv	2021-05-27	2021-05-28	16,918	—	$0	16,918	SEC↗
GOWEN MAXINE	Director	A Award deriv	2021-05-27	2021-06-01	4,542	—	$0	4,542	SEC↗
Goldsmith Bruce A	CEO and President	P Buy	2021-05-21	2021-05-21	2,000	$13.12	$26.2K	5,983	SEC↗
Morris Richard Steven	Chief Financial Officer	P Buy	2021-05-21	2021-05-21	2,171	$13.82	$30.0K	5,454	SEC↗
Fotopoulos Alexandros	Chief Technical Officer	A Award deriv	2021-05-17	2021-05-19	50,000	—	$0	50,000	SEC↗
Salinas Eliseo Oreste	Chief Res. & Develop Officer	A Award deriv	2021-03-22	2021-03-29	40,000	—	$0	40,000	SEC↗
Salinas Eliseo Oreste	Chief Res. & Develop Officer	A Award deriv	2021-03-22	2021-03-29	275,000	—	$0	275,000	SEC↗
Salinas Eliseo Oreste	Chief Res. & Develop Officer	A Award deriv	2021-03-22	2021-03-29	60,000	—	$0	60,000	SEC↗
Romano Gary	Chief Medical Officer	M Exercise deriv	2021-03-15	2021-03-17	10,000	—	$0	300,821	SEC↗
Romano Gary	Chief Medical Officer	S Sale	2021-03-15	2021-03-17	1,617	$21.86	$35.3K	0	SEC↗
Romano Gary	Chief Medical Officer	S Sale	2021-03-15	2021-03-17	8,383	$20.95	$175.6K	1,617	SEC↗
Romano Gary	Chief Medical Officer	M Exercise	2021-03-15	2021-03-17	10,000	$8.07	$80.7K	10,000	SEC↗
GOWEN MAXINE	Director	A Award deriv	2021-02-18	2021-02-22	33,836	—	$0	33,836	SEC↗
Fotopoulos Alexandros	Chief Technical Officer	A Award deriv	2021-02-16	2021-02-18	105,000	—	$0	105,000	SEC↗
Goldsmith Bruce A	CEO and President	A Award deriv	2021-02-16	2021-02-18	262,000	—	$0	262,000	SEC↗
Cale Edgar B.	GC and Corporate Secretary	A Award deriv	2021-02-16	2021-02-18	170,997	—	$0	170,997	SEC↗
Romano Gary	Chief Medical Officer	A Award deriv	2021-02-16	2021-02-18	105,000	—	$0	105,000	SEC↗
Morris Richard Steven	Chief Financial Officer	A Award deriv	2021-02-16	2021-02-18	50,000	—	$0	50,000	SEC↗
Quigley Jill M.	Chief Operating Officer	A Award deriv	2021-02-16	2021-02-18	105,000	—	$0	105,000	SEC↗
Quigley Jill M.	Chief Operating Officer	S Sale	2021-01-20	2021-01-22	1,300	$30.01	$39.0K	295,284	SEC↗
Quigley Jill M.	Chief Operating Officer	S Sale	2021-01-14	2021-01-15	16,298	$30.10	$490.6K	296,584	SEC↗
Countouriotis Athena	Director	P Buy	2020-03-24	2020-03-25	10,000	$14.98	$149.8K	18,900	SEC↗
Heron Patrick J	Director, 10% Owner	C Conversion deriv	2020-03-03	2020-03-03	432,802	—	$0	0	SEC↗
Heron Patrick J	Director, 10% Owner	C Conversion deriv	2020-03-03	2020-03-03	1,049,175	—	$0	0	SEC↗
Heron Patrick J	Director, 10% Owner	C Conversion deriv	2020-03-03	2020-03-03	2,977,242	—	$0	0	SEC↗
Woiwode Thomas	Director, 10% Owner	C Conversion deriv	2020-03-03	2020-03-03	2,977,242	—	$0	0	SEC↗
Woiwode Thomas	Director, 10% Owner	C Conversion deriv	2020-03-03	2020-03-03	1,049,175	—	$0	0	SEC↗
Woiwode Thomas	Director, 10% Owner	C Conversion deriv	2020-03-03	2020-03-03	708,352	—	$0	0	SEC↗
FHMLS IX, L.P.	10% Owner	C Conversion deriv	2020-03-03	2020-03-03	2,977,242	—	$0	0	SEC↗
FHMLS IX, L.P.	10% Owner	C Conversion deriv	2020-03-03	2020-03-03	1,049,175	—	$0	0	SEC↗
FHMLS IX, L.P.	10% Owner	C Conversion deriv	2020-03-03	2020-03-03	432,802	—	$0	0	SEC↗
Versant Ventures VI GP, L.P.	10% Owner	C Conversion deriv	2020-03-03	2020-03-03	1,049,175	—	$0	0	SEC↗
Versant Ventures VI GP, L.P.	10% Owner	C Conversion deriv	2020-03-03	2020-03-03	708,352	—	$0	0	SEC↗
Versant Ventures VI GP, L.P.	10% Owner	C Conversion deriv	2020-03-03	2020-03-03	2,977,242	—	$0	0	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	C Conversion deriv	2020-03-03	2020-03-03	1,311,469	—	$0	0	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	C Conversion deriv	2020-03-03	2020-03-03	541,002	—	$0	0	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	C Conversion deriv	2020-03-03	2020-03-03	3,721,552	—	$0	0	SEC↗
Ratcliffe Liam	Director	C Conversion deriv	2020-03-03	2020-03-13	2,066,630	—	$0	0	SEC↗
Cale Edgar B.	GC and Corporate Secretary	P Buy	2020-03-03	2020-03-03	2,000	$18.00	$36.0K	2,000	SEC↗
Countouriotis Athena	Director	P Buy	2020-03-03	2020-03-03	8,900	$18.00	$160.2K	8,900	SEC↗
Fotopoulos Alexandros	Chief Technical Officer	P Buy	2020-03-03	2020-03-03	5,500	$18.00	$99.0K	5,500	SEC↗
Goldsmith Bruce A	CEO and President	P Buy	2020-03-03	2020-03-03	1,100	$18.00	$19.8K	1,100	SEC↗
Islam Saqib	Director	P Buy	2020-03-03	2020-03-03	5,000	$18.00	$90.0K	5,000	SEC↗
Kapadia Sandip	Director	P Buy	2020-03-03	2020-03-03	5,000	$18.00	$90.0K	5,000	SEC↗
Morris Richard Steven	Chief Financial Officer	P Buy	2020-03-03	2020-03-03	400	$18.00	$7.2K	400	SEC↗
Quigley Jill M.	Chief Operating Officer	P Buy	2020-03-03	2020-03-03	1,500	$18.00	$27.0K	311,494	SEC↗
Quigley Jill M.	Chief Operating Officer	P Buy	2020-03-03	2020-03-03	1,000	$18.00	$18.0K	1,000	SEC↗
Ratcliffe Liam	Director	P Buy	2020-03-03	2020-03-03	2,800	$18.00	$50.4K	2,800	SEC↗
Yamada Tadataka	Director	P Buy	2020-03-03	2020-03-03	6,500	$18.00	$117.0K	656,149	SEC↗
Heron Patrick J	Director, 10% Owner	C Conversion	2020-03-03	2020-03-03	2,977,242	—	$0	2,977,242	SEC↗
Heron Patrick J	Director, 10% Owner	C Conversion	2020-03-03	2020-03-03	1,049,175	—	$0	4,026,417	SEC↗
Heron Patrick J	Director, 10% Owner	C Conversion	2020-03-03	2020-03-03	432,802	—	$0	4,459,219	SEC↗
Heron Patrick J	Director, 10% Owner	P Buy	2020-03-03	2020-03-03	550,000	$18.00	$9.90M	5,009,219	SEC↗
Woiwode Thomas	Director, 10% Owner	C Conversion	2020-03-03	2020-03-03	2,977,242	—	$0	2,977,242	SEC↗
Woiwode Thomas	Director, 10% Owner	C Conversion	2020-03-03	2020-03-03	1,049,175	—	$0	4,026,417	SEC↗
Woiwode Thomas	Director, 10% Owner	C Conversion	2020-03-03	2020-03-03	708,352	—	$0	708,352	SEC↗
Woiwode Thomas	Director, 10% Owner	P Buy	2020-03-03	2020-03-03	225,000	$18.00	$4.05M	933,352	SEC↗
FHMLS IX, L.P.	10% Owner	C Conversion	2020-03-03	2020-03-03	432,802	—	$0	4,459,219	SEC↗
FHMLS IX, L.P.	10% Owner	C Conversion	2020-03-03	2020-03-03	2,977,242	—	$0	2,977,242	SEC↗
FHMLS IX, L.P.	10% Owner	C Conversion	2020-03-03	2020-03-03	1,049,175	—	$0	4,026,417	SEC↗
FHMLS IX, L.P.	10% Owner	P Buy	2020-03-03	2020-03-03	550,000	$18.00	$9.90M	5,009,219	SEC↗
Versant Ventures VI GP, L.P.	10% Owner	C Conversion	2020-03-03	2020-03-03	1,049,175	—	$0	4,026,417	SEC↗
Versant Ventures VI GP, L.P.	10% Owner	C Conversion	2020-03-03	2020-03-03	708,352	—	$0	708,352	SEC↗
Versant Ventures VI GP, L.P.	10% Owner	P Buy	2020-03-03	2020-03-03	225,000	$18.00	$4.05M	933,352	SEC↗
Versant Ventures VI GP, L.P.	10% Owner	C Conversion	2020-03-03	2020-03-03	2,977,242	—	$0	2,977,242	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	C Conversion	2020-03-03	2020-03-03	3,721,552	—	$0	4,094,852	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	C Conversion	2020-03-03	2020-03-03	1,311,469	—	$0	5,406,321	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	C Conversion	2020-03-03	2020-03-03	541,002	—	$0	5,947,323	SEC↗
Ratcliffe Liam	Director	P Buy	2020-03-03	2020-03-13	2,800	$18.00	$50.4K	2,800	SEC↗
Ratcliffe Liam	Director	C Conversion	2020-03-03	2020-03-13	2,066,630	—	$0	2,066,630	SEC↗
Ratcliffe Liam	Director	P Buy	2020-03-03	2020-03-13	550,000	$18.00	$9.90M	2,616,630	SEC↗
OrbiMed Capital GP VII LLC	10% Owner	P Buy	2020-02-28	2020-03-03	373,300	$18.00	$6.72M	373,300	SEC↗
SQUINTO STEPHEN P	Head of Research and Dev	A Award deriv	2020-02-27	2020-03-02	185,776	—	$0	185,776	SEC↗
SQUINTO STEPHEN P	Head of Research and Dev	A Award deriv	2020-02-27	2020-03-02	33,836	—	$0	33,836	SEC↗
Quigley Jill M.	Chief Operating Officer	A Award deriv	2020-02-27	2020-03-02	211,001	—	$0	211,001	SEC↗
Morris Richard Steven	Chief Financial Officer	A Award deriv	2020-02-27	2020-03-02	74,311	—	$0	74,311	SEC↗
Romano Gary	Chief Medical Officer	A Award deriv	2020-02-27	2020-03-02	74,311	—	$0	74,311	SEC↗
Fotopoulos Alexandros	Chief Technical Officer	A Award deriv	2020-02-27	2020-03-02	74,311	—	$0	74,311	SEC↗
Cale Edgar B.	GC and Corporate Secretary	A Award deriv	2020-02-27	2020-03-02	99,731	—	$0	99,731	SEC↗
Heron Patrick J	Director, 10% Owner	A Award deriv	2020-02-27	2020-03-02	33,836	—	$0	33,836	SEC↗
Islam Saqib	Director	A Award deriv	2020-02-27	2020-03-02	16,918	—	$0	16,918	SEC↗
Kapadia Sandip	Director	A Award deriv	2020-02-27	2020-03-02	16,918	—	$0	16,918	SEC↗
Ratcliffe Liam	Director	A Award deriv	2020-02-27	2020-03-02	33,836	—	$0	33,836	SEC↗
Woiwode Thomas	Director, 10% Owner	A Award deriv	2020-02-27	2020-03-02	33,836	—	$0	33,836	SEC↗
Yamada Tadataka	Director	A Award deriv	2020-02-27	2020-03-02	33,836	—	$0	33,836	SEC↗
Countouriotis Athena	Director	A Award deriv	2020-02-27	2020-03-02	33,836	—	$0	33,836	SEC↗